Fingerprint
Dive into the research topics of 'Alemtuzumab markedly reduces chronic GVHD without affecting overall survival in reduced-intensity conditioning sibling allo-SCT for adults with AML'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically